Designed as a practical, succinct guide, for quick reference by clinicians with everyday
questions, this title guides the reader through the range of approaches available for …

Thrombotic and cardiovascular events are among the leading causes of death for patients
with polycythemia vera (PV), and thrombosis history is a key criterion for patient risk …

Rat inferior caval vein (ICV) ligation (up to the right ovarian vein (ROV)) commonly
represents a recapitulation of Virchow: with ligation leading to vessel injury, stasis …

Objectives To estimate the overall risk of venous thromboembolism (VTE), pulmonary
embolism (PE) and deep vein thrombosis (DVT) among patients newly diagnosed with RA …

We aim to develop a nanodroplet (ND)-mediated intravascular ultrasound (US) transducer
for deep vein thrombosis treatments. The US device, having an efficient forward directivity of …

Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide
BPC 157, particular anti-ulcer peptide that heals different organs lesions when given as a …

Multiple factors contribute to the risk of venous thromboembolism (VTE). Platelets have
attracted much interest in arterial cardiovascular disease, whereas their role in VTE has …

Background Critically ill infants are susceptible to thrombosis due to several risk factors. The
aim of this study was to identify risk factors associated with venous and arterial thrombosis in …

SARS-CoV-2 is the causative agent of COVID-19. Severe COVID-19 disease has been
associated with disseminated intravascular coagulation and thrombosis, but the …

The glycosaminoglycans (GAGs) heparan sulfate, dermatan sulfate, and heparin are
important anticoagulants that inhibit clot formation through interactions with antithrombin and …